Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02569905
Other study ID # 2014032605
Secondary ID
Status Completed
Phase Phase 4
First received October 1, 2015
Last updated October 23, 2015
Start date April 2014
Est. completion date April 2015

Study information

Verified date October 2015
Source Guangxi Medical University
Contact n/a
Is FDA regulated No
Health authority China: Health and Family Planning Commission of Guangxi Zhuang Autonomous Region
Study type Interventional

Clinical Trial Summary

Shivering is an early postoperative complication during the postoperative recovery period, and there is no clear consensus about the best way for its prevention. The aim of the study was to compare the efficacy and accompanying side effects of prophylactic flurbiprofen with that of parecoxib or placebo for reducing postoperative shivering.


Description:

154 patients with American Society of Anesthesiologists physical status I-II, who were scheduled for colorectal operation under general anesthesia, were randomly assigned to receive flurbiprofen (Group F), parecoxib sodium (Group P ) or normal saline(Group S)40min before the end of surgery. Hemodynamic parameters were monitored. The occurrence of shivering postoperative nausea and vomiting were recorded during the recovery period. And visual analogue score (VAS) and ramsy sedation scale (RSS) were also recorded.


Recruitment information / eligibility

Status Completed
Enrollment 166
Est. completion date April 2015
Est. primary completion date April 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 21 Years to 62 Years
Eligibility Inclusion Criteria:

- One hundred and sixty-six, American Society of Anesthesiologists' (ASA) physical status1or2, patients, undergoing colorectal operation were selected in the prospective, randomized, double-blind clinical study.

- All patients who were from 21 to 62 years old and body mass index 19-35 in tumor hospital of Guangxi medical university (State of China) from April 2014 to April 2015 were included.

Exclusion Criteria:

- Patients with cardiac, pulmonary, hepatic, renal, thyroid, or neuromuscular disease, and those who took chronic drug or abused alcohol were excluded.

- Another patients with hypertension, gastrointestinal bleeding, an initial core temperature >37.5? or <36.5?, a history of allergy to non- steroidal anti-inflammatory drugs (NSAIDs) or other agents to be used, and inability to cooperate were also excluded in this study.

- Another patients with blood loss during operation>400ml, a need for blood transfusion during surgery, duration of operation>4h and surgical procedures changed were excluded.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
parecoxib sodium
parecoxib sodium 40mg
flurbiprofen
flurbiprofen 50mg
saline
normal saline

Locations

Country Name City State
China Anesthesia Department, Tumor Hospital of Guangxi Medical University Nanning Guangxi

Sponsors (1)

Lead Sponsor Collaborator
Guangxi Medical University

Country where clinical trial is conducted

China, 

References & Publications (11)

Ayrian E, Kaye AD, Varner CL, Guerra C, Vadivelu N, Urman RD, Zelman V, Lumb PD, Rosa G, Bilotta F. Effects of Anesthetic Management on Early Postoperative Recovery, Hemodynamics and Pain After Supratentorial Craniotomy. J Clin Med Res. 2015 Oct;7(10):731-41. doi: 10.14740/jocmr2256w. Epub 2015 Aug 23. Review. — View Citation

Buggy DJ, Crossley AW. Thermoregulation, mild perioperative hypothermia and postanaesthetic shivering. Br J Anaesth. 2000 May;84(5):615-28. Review. — View Citation

Chen J, Chen Y, Lu KZ. Prophylactic parecoxib reduces the incidence of shivering after general anaesthesia. Eur J Anaesthesiol. 2014 Dec;31(12):714-5. doi: 10.1097/EJA.0000000000000165. — View Citation

Kilbas Z, Mentes MÖ, Harlak A, Yigit T, Balkan SM, Cosar A, Öztürk E, Kozak O, Tufan CT. Efficacy of wound infiltration with lornoxicam for postoperative analgesia following thyroidectomy: a prospective, randomized, double-blind study. Turk J Med Sci. 2015;45(3):700-5. — View Citation

Li X, Zhou M, Xia Q, Li W, Zhang Y. Effect of parecoxib sodium on postoperative shivering: a randomised, double-blind clinical trial. Eur J Anaesthesiol. 2014 Apr;31(4):225-30. doi: 10.1097/01.EJA.0000436684.94403.1e. — View Citation

Liu ZX, Xu FY, Liang X, Zhou M, Wu L, Wu JR, Xia JH, Zou Z. Efficacy of dexmedetomidine on postoperative shivering: a meta-analysis of clinical trials. Can J Anaesth. 2015 Jul;62(7):816-29. doi: 10.1007/s12630-015-0368-1. Epub 2015 Apr 8. Review. — View Citation

Park SM, Mangat HS, Berger K, Rosengart AJ. Efficacy spectrum of antishivering medications: meta-analysis of randomized controlled trials. Crit Care Med. 2012 Nov;40(11):3070-82. doi: 10.1097/CCM.0b013e31825b931e. Review. — View Citation

Shen H, Chen Y, Lu KZ, Chen J. Parecoxib for the prevention of shivering after general anesthesia. J Surg Res. 2015 Jul;197(1):139-44. doi: 10.1016/j.jss.2015.03.011. Epub 2015 Mar 28. — View Citation

Teymourian H, Mohajerani SA, Bagheri P, Seddighi A, Seddighi AS, Razavian I. Effect of Ondansetron on Postoperative Shivering After Craniotomy. World Neurosurg. 2015 Dec;84(6):1923-8. doi: 10.1016/j.wneu.2015.08.034. Epub 2015 Sep 3. — View Citation

Yang X, Peng N, Li N, Li J. Effect of cyclooxygenase-2-specific inhibitors on postoperative analgesia after major open abdominal surgery. Pain Manag Nurs. 2015 Jun;16(3):242-8. doi: 10.1016/j.pmn.2014.07.004. — View Citation

Yared JP, Starr NJ, Hoffmann-Hogg L, Bashour CA, Insler SR, O'Connor M, Piedmonte M, Cosgrove DM 3rd. Dexamethasone decreases the incidence of shivering after cardiac surgery: a randomized, double-blind, placebo-controlled study. Anesth Analg. 1998 Oct;87(4):795-9. — View Citation

* Note: There are 11 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary shivering in one hour after extubation. Yes
Secondary visual analogue score at the time of extubation, 30min and 60min after extubation. Yes
Secondary sedation scores at the time of extubation, 30min and 60min after extubation. Yes
Secondary incidence of postoperative nausea and vomiting in one hour after extubation. Yes
See also
  Status Clinical Trial Phase
Recruiting NCT04654429 - Does Higher OT Temperature and IV Ondansetron Reduce Incidence of PSS in Parturients? Phase 4
Active, not recruiting NCT02965586 - Efficacy of Intrathecal Versus Intravenous Dexmedetomidine for Prevention of Post Spinal Anesthesia Shivering Phase 1/Phase 2
Completed NCT05427149 - The Effect of Intrathecal Magnesium Sulfate on Shivering N/A
Completed NCT04133961 - Intraoperative Phenylephrine Infusion to Reduce Postoperative Shivering in Lower Segment Caesarean Section N/A
Completed NCT06238739 - Optimal Temperature Control in Body Contouring Procedures N/A
Not yet recruiting NCT05952752 - Dexemedetomidine on Shivering Cesarean Section Under Spinal Anesthesia A Randomized Clinical Trial N/A
Recruiting NCT04735965 - Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft Phase 4
Completed NCT01793558 - Incidence and Prevention of Hypothermia in Newborns Bonding During Caesarean Section N/A
Completed NCT05718011 - Prevention of Shivering After Spinal Anesthesia Phase 4
Recruiting NCT05342376 - Intravenous Dexmeditomidine for Prevention of Spinal Anesthesia Induced Shivering. Phase 4